头孢地尔在一名患有广泛耐药鲍曼不动杆菌和产KPC肺炎克雷伯菌的重症患者中同情用药的成功治疗：一例报告 - Suppr

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.

作者信息

Trecarichi Enrico Maria, Quirino Angela, Scaglione Vincenzo, Longhini Federico, Garofalo Eugenio, Bruni Andrea, Biamonte Eugenio, Lionello Rosaria, Serapide Francesca, Mazzitelli Maria, Marascio Nadia, Matera Giovanni, Liberto Maria Carla, Navalesi Paolo, Torti Carlo

机构信息

Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.

Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.

出版信息

J Antimicrob Chemother. 2019 Nov 1;74(11):3399-3401. doi: 10.1093/jac/dkz318.

DOI:10.1093/jac/dkz318

PMID:31369095

Abstract

摘要

相似文献

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.

J Antimicrob Chemother. 2019 Nov 1;74(11):3399-3401. doi: 10.1093/jac/dkz318.

Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2069-74. doi: 10.1007/s10096-015-2453-3. Epub 2015 Aug 4.

Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.

Mar Drugs. 2015 Apr 14;13(4):2287-305. doi: 10.3390/md13042287.

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00700-17. Print 2017 Sep.

Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.

PLoS One. 2020 Jun 9;15(6):e0233704. doi: 10.1371/journal.pone.0233704. eCollection 2020.

Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.

Chin Med Sci J. 2014 Mar;29(1):51-4. doi: 10.1016/s1001-9294(14)60025-0.

Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.

J Clin Microbiol. 2009 May;47(5):1613. doi: 10.1128/JCM.00404-09.

Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.

Microb Drug Resist. 2021 Sep;27(9):1167-1175. doi: 10.1089/mdr.2020.0489. Epub 2021 Feb 17.

Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.

Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01872-19.

Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii.

J Glob Antimicrob Resist. 2020 Dec;23:292-296. doi: 10.1016/j.jgar.2020.09.019. Epub 2020 Oct 13.

引用本文的文献

Carbapenem-Resistant spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.

Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. eCollection 2023 Jul.

Activity of Cefiderocol Against Carbapenem-Resistant Clinical Isolates: a Single Center Experience.

Mediterr J Hematol Infect Dis. 2023 Jul 1;15(1):e2023043. doi: 10.4084/MJHID.2023.043. eCollection 2023.

Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.

Ann Intensive Care. 2023 Jun 15;13(1):52. doi: 10.1186/s13613-023-01146-5.

Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic.

Microorganisms. 2023 Apr 10;11(4):984. doi: 10.3390/microorganisms11040984.

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales.

Infect Dis Ther. 2023 Mar;12(3):777-806. doi: 10.1007/s40121-023-00773-6. Epub 2023 Feb 25.

The Role of Novel Antibiotics in the Management of Diabetic Foot Infection.

Diabetes Ther. 2023 Feb;14(2):251-263. doi: 10.1007/s13300-022-01357-2. Epub 2022 Dec 24.

Successful Treatment of Aortic Endocarditis by with Cefiderocol Combination Therapy in a Non-Hodgkin Lymphoma Patient: Case Report and Literature Review.

Antibiotics (Basel). 2022 Nov 23;11(12):1686. doi: 10.3390/antibiotics11121686.

The role of cefiderocol in clinical practice.

Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):39-44. doi: 10.37201/req/s02.06.2022. Epub 2022 Oct 4.

Clinical experience of cefiderocol.

Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):35-38. doi: 10.37201/req/s02.05.2022. Epub 2022 Oct 4.

Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.

Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):1-15. doi: 10.37201/req/s02.01.2022. Epub 2022 Oct 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献